Celadon Pharmaceuticals Plc (AIM: CEL)
37.00
-15.50 (-29.52%)
Sep 11, 2024, 5:37 PM GMT+1
Celadon Pharmaceuticals Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Aug '20 Aug 31, 2020 | 2019 |
Cash & Equivalents | 1.26 | 1.26 | 5.06 | 3.82 | 0.3 | 5.49 | Upgrade
|
Cash & Short-Term Investments | 1.26 | 1.26 | 5.06 | 3.82 | 0.3 | 5.49 | Upgrade
|
Cash Growth | -75.12% | -75.12% | 32.38% | 1176.55% | -94.54% | 369212.99% | Upgrade
|
Accounts Receivable | 0.08 | 0.08 | - | 0.06 | - | - | Upgrade
|
Other Receivables | 0.77 | 0.77 | 1.06 | 0.04 | 0.15 | 0 | Upgrade
|
Receivables | 0.84 | 0.84 | 1.06 | 0.1 | 0.15 | 0 | Upgrade
|
Inventory | 0.1 | 0.1 | 0.02 | 0 | - | - | Upgrade
|
Prepaid Expenses | 0.3 | 0.3 | 0.19 | 0.16 | 0.04 | 0.01 | Upgrade
|
Other Current Assets | - | - | - | - | 0.25 | - | Upgrade
|
Total Current Assets | 2.5 | 2.5 | 6.33 | 4.09 | 0.74 | 5.5 | Upgrade
|
Property, Plant & Equipment | 6.18 | 6.18 | 6.28 | 3.31 | 3.03 | - | Upgrade
|
Long-Term Investments | 0.22 | 0.22 | 0.22 | 0.2 | - | - | Upgrade
|
Goodwill | 0.08 | 0.08 | 0.08 | 0.72 | 0.08 | - | Upgrade
|
Other Intangible Assets | 0.25 | 0.25 | 0.35 | 0.45 | - | - | Upgrade
|
Total Assets | 9.22 | 9.22 | 13.25 | 8.76 | 3.85 | 5.5 | Upgrade
|
Accounts Payable | 0.33 | 0.33 | 0.54 | 0.16 | 0.26 | 0 | Upgrade
|
Accrued Expenses | 0.45 | 0.45 | 0.48 | 0.52 | 0.1 | 0.03 | Upgrade
|
Short-Term Debt | - | - | - | 4.93 | - | - | Upgrade
|
Current Portion of Long-Term Debt | 0.02 | 0.02 | 0.01 | 2.17 | 0.01 | - | Upgrade
|
Current Portion of Leases | 0.05 | 0.05 | 0.06 | 0.34 | - | - | Upgrade
|
Current Income Taxes Payable | 0.08 | 0.08 | 0.09 | 0.07 | - | 0 | Upgrade
|
Other Current Liabilities | - | - | - | 0.38 | 0.47 | 0.01 | Upgrade
|
Total Current Liabilities | 0.96 | 0.96 | 1.2 | 8.58 | 0.83 | 0.04 | Upgrade
|
Long-Term Debt | 0.01 | 0.01 | 0.02 | 1.57 | 0.04 | - | Upgrade
|
Long-Term Leases | 4.63 | 4.63 | 4.54 | 2.92 | 2.87 | - | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.04 | 0.04 | 0.06 | 0.09 | - | - | Upgrade
|
Other Long-Term Liabilities | 0.41 | 0.41 | 0.39 | - | 0 | - | Upgrade
|
Total Liabilities | 6.04 | 6.04 | 6.21 | 13.16 | 3.75 | 0.04 | Upgrade
|
Common Stock | 0.64 | 0.64 | 0.62 | 0.08 | 0 | 0.06 | Upgrade
|
Additional Paid-In Capital | 25.5 | 25.5 | 22.55 | 7.37 | 1.27 | 5.71 | Upgrade
|
Retained Earnings | -30.73 | -30.73 | -22.81 | -5.8 | -1.17 | -0.37 | Upgrade
|
Comprensive Income & Other | 7.74 | 7.74 | 7.31 | -5.79 | - | 0.05 | Upgrade
|
Total Common Equity | 3.16 | 3.16 | 7.68 | -4.14 | 0.1 | 5.46 | Upgrade
|
Minority Interest | 0.02 | 0.02 | -0.64 | -0.26 | - | - | Upgrade
|
Shareholders' Equity | 3.18 | 3.18 | 7.04 | -4.4 | 0.1 | 5.46 | Upgrade
|
Total Liabilities & Equity | 9.22 | 9.22 | 13.25 | 8.76 | 3.85 | 5.5 | Upgrade
|
Total Debt | 4.72 | 4.72 | 4.63 | 11.92 | 2.92 | - | Upgrade
|
Net Cash (Debt) | -3.46 | -3.46 | 0.43 | -8.1 | -2.62 | 5.49 | Upgrade
|
Net Cash Per Share | -0.06 | -0.06 | 0.01 | -0.18 | -85.27 | 0.90 | Upgrade
|
Filing Date Shares Outstanding | 64.21 | 64.21 | 61.67 | 8.03 | 0.03 | 6.13 | Upgrade
|
Total Common Shares Outstanding | 64.21 | 64.21 | 61.67 | 8.03 | 0.03 | 6.13 | Upgrade
|
Working Capital | 1.55 | 1.55 | 5.13 | -4.5 | -0.1 | 5.46 | Upgrade
|
Book Value Per Share | 0.05 | 0.05 | 0.12 | -0.52 | 3.22 | 0.89 | Upgrade
|
Tangible Book Value | 2.83 | 2.83 | 7.25 | -5.31 | 0.02 | 5.46 | Upgrade
|
Tangible Book Value Per Share | 0.04 | 0.04 | 0.12 | -0.66 | 0.61 | 0.89 | Upgrade
|
Machinery | 1.35 | 1.35 | 1.1 | 0.79 | 0.51 | - | Upgrade
|
Construction In Progress | 2.01 | 2.01 | 1.99 | - | - | - | Upgrade
|
Leasehold Improvements | 0.3 | 0.3 | 0.25 | 0.47 | 0.2 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.